[Morphogenetic and functional changes in edema-proteinuria-hypertension pregnancy toxemias. II].
D001791:Blood Platelet Disorders / Q000503:physiopathology*; D002585:Cesarean Section; D002719:Chlormethiazole / Q000627:therapeutic use; D003250:Constriction; D004487:Edema / Q000209:etiology*; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000209:etiology*; D007226:Infant Mortality; D007263:Infusions, Parenteral; D009638:Norepinephrine / Q000378:metabolism; D011225:Pre-Eclampsia / Q000145:classification / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy; D011247:Pregnancy; D011507:Proteinuria / Q000209:etiology*; D012701:Serotonin / Q000378:metabolism; D014546:Urinary Catheterization; D014666:Vasomotor System / Q000503:physiopathology*
D002719:Chlormethiazole; D012701:Serotonin; D006493:Heparin; D009638:Norepinephrine
Morphogenetische und funktionelle Veränderungen bei EPH-Gestose. II.